17 alpha-hydroxylase deficiency risk factors: Difference between revisions
No edit summary |
Iqra Qamar (talk | contribs) |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{Ammu}}, {{MJ}} | {{CMG}}; {{AE}} {{Ammu}}, {{MJ}} | ||
==Overview== | ==Overview== | ||
The most potent risk factor | The most potent risk factor for the development of 17 alpha-hydroxylase deficiency is a positive [[family history]] of 17 alpha-hydroxylase deficiency. | ||
==Risk Factors== | ==Risk Factors== | ||
Revision as of 12:06, 23 October 2017
|
17 alpha-hydroxylase deficiency Microchapters |
|
Differentiating 17 alpha-hydroxylase deficiency from other Diseases |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
17 alpha-hydroxylase deficiency risk factors On the Web |
|
American Roentgen Ray Society Images of 17 alpha-hydroxylase deficiency risk factors |
|
Risk calculators and risk factors for 17 alpha-hydroxylase deficiency risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2], Mehrian Jafarizade, M.D [3]
Overview
The most potent risk factor for the development of 17 alpha-hydroxylase deficiency is a positive family history of 17 alpha-hydroxylase deficiency.
Risk Factors
The most potent risk factor in the development of 17 alpha-hydroxylase deficiency is presence of family history of 17 alpha-hydroxylase deficiency.[1]
References
- ↑ Hannah-Shmouni F, Chen W, Merke DP (2017). "Genetics of Congenital Adrenal Hyperplasia". Endocrinol. Metab. Clin. North Am. 46 (2): 435–458. doi:10.1016/j.ecl.2017.01.008. PMID 28476231.